Open Access Repository

Item Statistical Overview

All items > Item: PD-L1 test-based strategy with Nivolumab as the second-line treatment in advanced NSCLC: A cost-effectiveness analysis in China
Downloads
Activity Overview
6Downloads
14Hits
TOP